TALEN

TALEN3-klf2a

ID

ZDB-TALEN-190604-1

Name

TALEN3-klf2a

Previous Names

None

Target

klf2a (1)

Target Sequence 1

5' - GACACCTACTGCCAACCGTCT - 3'

Target Sequence 2

5' - GGGGAAAGCAGGCCTGACT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
bns11	klf2a

Expression

Gene expression in Wild Types + TALEN3-klf2a

No data available

Phenotype

Phenotype resulting from TALEN3-klf2a

No data available

Phenotype of all Fish created by or utilizing TALEN3-klf2a

Phenotype	Fish	Conditions	Figures
cardiac muscle cell protruding out of compact layer of ventricle, exacerbated	klf2a^bns11/+; klf2b^bns12/bns12; s883Tg	chemical treatment by environment: SU5402	Fig. 6 from Rasouli et al., 2018
ventricular myocardium ventricular cardiac muscle tissue morphogenesis decreased process quality, exacerbated	klf2a^bns11/+; klf2b^bns12/bns12; s883Tg	chemical treatment by environment: SU5402	Fig. 6 from Rasouli et al., 2018
heart edematous, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12	standard conditions	Fig. 1 from Rasouli et al., 2018
ventricular endocardium MAPK cascade decreased occurrence, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; bns7Tg	standard conditions	Fig. 6 from Rasouli et al., 2018
ventricular myocardium ventricular cardiac muscle tissue morphogenesis decreased process quality, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; bns7Tg	standard conditions	Fig. 6 from Rasouli et al., 2018
cardiac muscle cell protruding out of compact layer of ventricle, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; bns7Tg	standard conditions	Fig. 6 from Rasouli et al., 2018
ventricular endocardium ab9-mapk labeling decreased amount, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; bns7Tg	standard conditions	Fig. 6 from Rasouli et al., 2018
ventricular myocardium cell population proliferation decreased occurrence, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; bns7Tg; ncv43Tg	standard conditions	Fig. 3 from Rasouli et al., 2018
cardiac muscle cell protruding out of compact layer of ventricle, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; hsc4Tg; s974Tg	standard conditions	Fig. 2 from Rasouli et al., 2018
ventricular myocardium ventricular cardiac muscle tissue morphogenesis decreased process quality, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; hsc4Tg; s974Tg	standard conditions	Fig. 2 from Rasouli et al., 2018
cardiac ventricle cardiac muscle contraction arrested, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; hsc4Tg; s974Tg	chemical treatment by environment: diacetylmonoxime	Fig. 2 from Rasouli et al., 2018
ventricular myocardium ventricular cardiac muscle tissue morphogenesis process quality, ameliorated	klf2a^bns11/bns11; klf2b^bns12/bns12; hsc4Tg; s974Tg	chemical treatment by environment: diacetylmonoxime	Fig. 2 from Rasouli et al., 2018
cardiac muscle cell located in compact layer of ventricle, ameliorated	klf2a^bns11/bns11; klf2b^bns12/bns12; hsc4Tg; s974Tg	chemical treatment by environment: diacetylmonoxime	Fig. 2 from Rasouli et al., 2018
atrium cardiac muscle contraction arrested, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; hsc4Tg; s974Tg	chemical treatment by environment: diacetylmonoxime	Fig. 2 from Rasouli et al., 2018
ventricular myocardium apical plasma membrane EGFP expression mislocalised, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; hsc4Tg; zf517Tg	standard conditions	Fig. 3 from Rasouli et al., 2018
cardiac muscle cell mislocalised radially, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; s883Tg	standard conditions	Fig. 1 from Rasouli et al., 2018
cardiac muscle cell protruding out of compact layer of ventricle, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; s883Tg	standard conditions	Fig. 1 , Fig. 5 from Rasouli et al., 2018
ventricular myocardium ventricular cardiac muscle tissue morphogenesis decreased process quality, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; s883Tg	standard conditions	Fig. 1 , Fig. 5 from Rasouli et al., 2018
cardiac muscle cell protruding out of compact layer of ventricle, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; s974Tg	standard conditions	Fig. 1 , Fig. 2 from Rasouli et al., 2018
cardiac muscle cell mislocalised radially, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; s974Tg	standard conditions	Fig. 1 from Rasouli et al., 2018
ventricular myocardium ventricular cardiac muscle tissue morphogenesis decreased process quality, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; s974Tg	standard conditions	Fig. 1 , Fig. 2 from Rasouli et al., 2018
ventricular myocardium ventricular cardiac muscle tissue morphogenesis decreased process quality, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; bns200Tg; s883Tg	standard conditions	Fig. 5 from Rasouli et al., 2018
cardiac muscle cell protruding out of compact layer of ventricle, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; bns200Tg; s883Tg	standard conditions	Fig. 5 from Rasouli et al., 2018
ventricular myocardium ventricular cardiac muscle tissue morphogenesis decreased process quality, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; bns234Tg; s883Tg	standard conditions	Fig. 5 from Rasouli et al., 2018
cardiac muscle cell protruding out of compact layer of ventricle, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; bns234Tg; s883Tg	standard conditions	Fig. 5 from Rasouli et al., 2018
heart morphology, ameliorated	klf2a^bns11/bns11; klf2b^bns12/bns12; bns235Tg	standard conditions	Fig. 5 from Rasouli et al., 2018
cardiac ventricle morphology, ameliorated	klf2a^bns11/bns11; klf2b^bns12/bns12; bns235Tg	standard conditions	Fig. 5 from Rasouli et al., 2018
ventricular myocardium ventricular cardiac muscle tissue morphogenesis process quality, ameliorated	klf2a^bns11/bns11; klf2b^bns12/bns12; bns235Tg	standard conditions	Fig. 5 from Rasouli et al., 2018
ventricular endocardium MAPK cascade occurrence, ameliorated	klf2a^bns11/bns11; klf2b^bns12/bns12; bns235Tg; s883Tg	standard conditions	Fig. 6 from Rasouli et al., 2018
cardiac muscle cell located in compact layer of ventricle, ameliorated	klf2a^bns11/bns11; klf2b^bns12/bns12; bns235Tg; s883Tg	standard conditions	Fig. 5 , Fig. 6 from Rasouli et al., 2018
ventricular endocardium ab9-mapk labeling amount, ameliorated	klf2a^bns11/bns11; klf2b^bns12/bns12; bns235Tg; s883Tg	standard conditions	Fig. 6 from Rasouli et al., 2018
ventricular myocardium ventricular cardiac muscle tissue morphogenesis process quality, ameliorated	klf2a^bns11/bns11; klf2b^bns12/bns12; bns235Tg; s883Tg	standard conditions	Fig. 5 , Fig. 6 from Rasouli et al., 2018
cardiac muscle cell located in compact layer of ventricle, ameliorated	klf2a^bns11/bns11; klf2b^bns12/bns12; s974Tg + MO1-tnnt2a	standard conditions	Fig. 2 from Rasouli et al., 2018
cardiac ventricle cardiac muscle contraction arrested, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; s974Tg + MO1-tnnt2a	standard conditions	Fig. 2 from Rasouli et al., 2018
ventricular myocardium ventricular cardiac muscle tissue morphogenesis process quality, ameliorated	klf2a^bns11/bns11; klf2b^bns12/bns12; s974Tg + MO1-tnnt2a	standard conditions	Fig. 2 from Rasouli et al., 2018
atrium cardiac muscle contraction arrested, abnormal	klf2a^bns11/bns11; klf2b^bns12/bns12; s974Tg + MO1-tnnt2a	standard conditions	Fig. 2 from Rasouli et al., 2018

Citations